Related Experiment Video

Updated: Apr 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand

Xavier Préville1, Karola Rittner1, Laetitia Fend1

  • 1Transgene S.A.; Illkirch-Graffenstaden ; Strasbourg, France.

Oncoimmunology
|July 9, 2015
PubMed

Insights

Modified Vaccinia virus Ankara combined with a toll-like receptor 9 agonist effectively controls renal carcinoma growth by directing CD8+ T-cell infiltration. This approach shows promise for enhancing tumor immunotherapy strategies.

Area of Science:

  • Oncolytic virotherapy
  • Immunotherapy
  • Renal cell carcinoma research

Background:

  • Orthotopic renal carcinoma presents a significant challenge in cancer treatment.
  • Current immunotherapies often require optimization for enhanced efficacy.
  • Modulating the tumor microenvironment is crucial for successful cancer control.

Purpose of the Study:

  • To evaluate the efficacy of Modified Vaccinia virus Ankara (MVA) in combination with a toll-like receptor 9 (TLR9) agonist.
  • To investigate the impact of this combination therapy on CD8+ T-cell infiltration in renal carcinoma.
  • To explore the potential for improved tumor immunotherapy protocols.

Main Methods:

  • Preclinical models of orthotopic renal carcinoma were utilized.
  • Intravenous administration of MVA was employed.
  • Combination therapy with a TLR9 agonist was assessed.

Main Results:

  • MVA induced significant infiltration of CD8+ lymphocytes into tumor-bearing organs.
  • The combination therapy demonstrated control over orthotopic renal carcinoma growth.
  • Evidence suggests a favorable modulation of the tumor microenvironment.

Conclusions:

  • Combination of MVA and a TLR9 agonist is a promising strategy for renal carcinoma.
  • Enhanced CD8+ T-cell infiltration contributes to tumor growth control.
  • This approach may form the basis for more effective clinical tumor immunotherapy protocols.
Keywords:
MUC1MVATLR9immunotherapyorthotopicrenal carcinoma

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

7.3K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K